Transcranial Magnetic Stimulation for Low Back Pain
Clinical Applicaitons of Non-Invasive Brain Stimulation for the Treatment of Chronic Pain
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304
- Stanford University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 or older
- Patient with Chronic Low Back Pain
- Meets minimum pain level criteria
- Ability to perform the experimental Task and Procedures
Exclusion Criteria:
- MRI contraindication if an MRI exam is required per protocol
- TMS Contraindication
- History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
- Neurologic illness that would interfere with brain integrity
- Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
- Currently pregnant or planning to become pregnant.
- On going legal action or disability claim.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: TMS Parameter Condition 1 first
Application of Transcranial Magnetic Stimulation
|
|
|
Experimental: TMS Parameter Condition 2 First
Application of Transcranial Magnetic Stimulation
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Average Daily Pain
Time Frame: Baseline Compared to each treatmeant series (at 4 weeks, 8 weeks, and 12 weeks)
|
Compared to baseline pain report as provided by Visual Analogue Scale (VAS)
|
Baseline Compared to each treatmeant series (at 4 weeks, 8 weeks, and 12 weeks)
|
|
Change in Worst Daily Pain
Time Frame: Baseline Compared to each treatment series (at 4 weeks, 8 weeks, and 12 weeks)
|
As compared to baseline worst daily pain report provided on visual analogue scale (VAS)
|
Baseline Compared to each treatment series (at 4 weeks, 8 weeks, and 12 weeks)
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 27678
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.